Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Hearing Questions Strength Of FDA Post-Market Surveillance

This article was originally published in The Gray Sheet

Executive Summary

An April 13 Senate hearing billed as a look at the medical device approval process turned into a wide-ranging critique of FDA's post-market surveillance of device safety.

You may also be interested in...



GAO Calls For Reforms In FDA Oversight Of Device Recalls

The Government Accountability Office is urging FDA to clarify and strengthen its oversight of medical device recalls.

GAO Calls For Reforms In FDA Oversight Of Device Recalls

The Government Accountability Office is urging FDA to clarify and strengthen its oversight of medical device recalls.

Class I Recalls Surge To Highest Point Ever; FDA Not Sure Why

The number of high-risk Class I medical device recalls skyrocketed to its highest point ever last year, leaving FDA officials to ponder what could have caused the dramatic upswing.

Related Content

UsernamePublicRestriction

Register

MT030054

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel